Inovelon е определен като “ лекарство сирак ” (лекарство за редки заболявания).
Because the number of patients with Lennox-Gastaut syndrome is low, the disease is rare, and Inovelon was designated an ‘ orphan medicine’ (a medicine used in rare diseases) on 20 October 2004.